Juva Life Inc.
JUVAF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $6 | $4 | $1 | $0 |
| % Growth | 50.4% | 296.3% | – | – |
| Cost of Goods Sold | $6 | $8 | $1 | $1 |
| Gross Profit | $0 | -$4 | $0 | -$1 |
| % Margin | 0.8% | -110.6% | 44.3% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $3 | $8 | $6 |
| SG&A Expenses | $8 | $5 | $11 | $6 |
| Sales & Mktg Exp. | $0 | $2 | $3 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Expenses | $8 | $6 | $11 | $7 |
| Operating Income | -$8 | -$10 | -$10 | -$7 |
| % Margin | -140.9% | -261% | -1,063.9% | – |
| Other Income/Exp. Net | -$2 | -$1 | -$6 | -$2 |
| Pre-Tax Income | -$10 | -$11 | -$16 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$11 | -$16 | -$9 |
| % Margin | -181.9% | -293.7% | -1,678.7% | – |
| EPS | -0.064 | -0.071 | -0.13 | -0.075 |
| % Growth | 10.5% | 45.1% | -73.8% | – |
| EPS Diluted | -0.064 | -0.071 | -0.13 | -0.075 |
| Weighted Avg Shares Out | 164 | 158 | 129 | 120 |
| Weighted Avg Shares Out Dil | 164 | 158 | 129 | 120 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $2 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$7 | -$10 | -$16 | -$6 |
| % Margin | -118.6% | -247.9% | -1,634.9% | – |